Applied Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APLT Nasdaq 2830 www.appliedtherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Applied Therapeutics, Inc.

Cycle Pharmaceuticals to Acquire Applied Therapeutics - Dec 11th, 2025 3:25 pm
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - Nov 27th, 2025 10:00 am
Applied Therapeutics Announces Corporate Updates - Nov 20th, 2025 5:00 am
BC-Most Active Stocks - Nov 17th, 2025 8:30 am
Can Changes in Leadership and FDA Dialogue Reshape Applied Therapeutics’ (APLT) Path in Rare Diseases? - Nov 14th, 2025 5:19 pm
Applied Therapeutics Reports Third Quarter 2025 Financial Results - Nov 13th, 2025 5:00 am
Institutional investors may adopt severe steps after Applied Therapeutics, Inc.'s (NASDAQ:APLT) latest 19% drop adds to a year losses - Oct 4th, 2025 7:46 am
Applied Therapeutics Provides Update Following Meeting with FDA - Sep 29th, 2025 5:00 am
Applied Therapeutics Reports Second Quarter 2025 Financial Results - Aug 13th, 2025 3:11 pm
Applied Therapeutics Announces Key Leadership Appointments - Jun 17th, 2025 2:05 pm
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - May 18th, 2025 5:28 am
Applied Therapeutics Reports First Quarter 2025 Financial Results - May 13th, 2025 3:00 pm
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - May 9th, 2025 3:00 pm
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - Apr 14th, 2025 3:50 pm
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - Mar 31st, 2025 5:10 am
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - Mar 19th, 2025 5:00 am
3 Penny Stocks With At Least $50M Market Cap - Mar 12th, 2025 11:05 am
Why pharma is still far from a treatment for galactosemia - Feb 28th, 2025 3:54 am
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock? - Feb 21st, 2025 1:24 am
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality - Jan 21st, 2025 5:00 am